Free Trial

Oruka Therapeutics (ORKA) Earnings Date, Estimates & Call Transcripts

Oruka Therapeutics logo
$9.98 -0.73 (-6.82%)
Closing price 05/5/2025 04:00 PM Eastern
Extended Trading
$9.99 +0.01 (+0.10%)
As of 05/5/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Oruka Therapeutics Earnings Summary

Upcoming
Earnings Date
May. 8Before Market OpensEstimated
Consensus EPS
(Mar. 6)
-$0.68
Actual EPS
(Mar. 6)
-$0.49 Beat By $0.19

Oruka Therapeutics announced Q4 2024 earnings on March 6, 2025, reporting an EPS of -$0.49, which beat the consensus estimate of -$0.68 by $0.19. With a trailing EPS of -$5.79, Oruka Therapeutics' earnings are expected to grow next year, from ($3.41) to ($2.92) per share.

Q4 2024 Earnings Resources

ORKA Upcoming Earnings

Oruka Therapeutics' Q1 2025 earnings is scheduled for Thursday, May 8, 2025, with a conference call scheduled on Tuesday, May 13, 2025 at 12:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Oruka Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Oruka Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ORKA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Oruka Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20253-$0.44-$0.31-$0.38
Q2 20253-$0.49-$0.37-$0.43
Q3 20253-$0.54-$0.37-$0.45
Q4 20253-$0.61-$0.46-$0.53
FY 2025 12 -$2.08 -$1.51 -$1.80
Q1 20262-$1.31-$0.62-$0.97
Q2 20262-$1.46-$0.67-$1.07
Q3 20261-$0.72-$0.72-$0.72
Q4 20261-$0.74-$0.74-$0.74

Oruka Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/8/2025
(Estimated)
--------
3/6/2025Q4 2024-$0.68-$0.49+$0.19-$0.49--
8/1/2024Q2 2024--$25.92 -$25.92-$2.16--
4/25/2024Q1 2024--$20.16 -$20.16-$1.68--
2/1/2024Q4 2023--$11.52 -$11.52-$0.96--
10/18/2023Q3 2023--$14.40 -$14.40-$1.20--
7/21/2023Q2 2023--$14.40 -$14.40-$1.20--

Oruka Therapeutics Earnings - Frequently Asked Questions

Oruka Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on ORKA's earnings history.

In the previous quarter, Oruka Therapeutics (NASDAQ:ORKA) reported ($0.49) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.68) by $0.19. Learn more on analysts' earnings estimate vs. ORKA's actual earnings.

Oruka Therapeutics (NASDAQ:ORKA) has a recorded net income of -$5.34 million. ORKA has generated -$5.79 earnings per share over the last four quarters.

Oruka Therapeutics's earnings are expected to grow from ($3.41) per share to ($2.92) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:ORKA) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners